Aligos Therapeutics, Inc. · NASDAQ:ALGS
Lawrence M. Blatt reported a 5.10% stake in Aligos Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Lawrence M. Blatt reported a 5.10% stake in Aligos Therapeutics, Inc., 286,213 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 286,213
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lawrence M. Blatt | 5.10% | 286,213 |
Source
Related
- Aligos Therapeutics, Inc.
- Lawrence M. Blatt
- Aligos Therapeutics, Inc. shareholders
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13D/A · Lawrence M. Blatt · Mar 12, 2025
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026
- Schedule 13G/A · Woodline Partners LP · Nov 14, 2025
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2025